 The 3CL protease of SARS-CoV-2 is inhibited by PF00835231 in vitro. Here, the authors show that the pro-drug PF07304814 has brought spectrum activity, inhibiting SARS-CoV and SARS-CoV-2 in mice and its ADME and safety profile support clinical development. This article was authored by Britain Boris, Rhys M. Jones, Brandon J. Anson, and others.